$QGEN News

Last published 2w ago

2w agoQGENEarnings Call - QIAGEN NVEarnings Call TranscriptsHey everybody, I'm Ben Busby. I've been a computational biologist for 20 years. Now I'm the omics alliances manager for NVIDIA and I really look forward to expanding this collaboration with you. So at NVIDA we have an am
3w agoQGENQIAGEN reports preliminary Q3 2026 resultsBusiness WireQIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates (CER). Adjusted diluted
3w agoQGENQIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offerBusiness WireQIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an offer price of €46.50 per share, a premium of 40.3% to the unaffected share price Following a
3w agoQGENThermo Fisher Scientific Q3 2026 Earnings Call - QIAGEN NVEarnings Call TranscriptsGood morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2026 third quarter conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a q
4w agoQGENQIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against TuberculosisBusiness WireGlobal TB Summit brings together international experts as persistent disease burden and funding pressures challenge progress against tuberculosis QuantiFERON-TB Gold Plus detects tuberculosis (TB) infection as an
1mo agoQGENQIAGEN Expands AI-Powered Bioinformatics for Research and Drug DiscoveryBusiness WireNew IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN Discovery Platform extends AI into drug discovery
1mo agoQGENQIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection PanelBusiness WireBloodstream infections can trigger sepsis, a life-threatening response to infection; about 1.7 million U.S. adults develop sepsis each year, contributing to at least 350,000 deaths New QIAstat-Dx test identifies
1mo agoQGENQIAGEN Launches QIAmini to Automate Small-Batch Sample PreparationBusiness WireCompact system offers research laboratories a time-saving and cost-efficient way to automate work still done by hand Reduction in hands-on time of over 80% compared with manual sample processing Third new sample
1mo agoQGENQIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing BoardBusiness WireQIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that it will hold an Extraordinary General Meeting of Shareholders on November 6, 2026, at 2:00 p.m. CET. Shareholders will be asked to vote on
1mo agoQGENBAIRD 2026 GLOBAL HEALTHCARE CONFERENCE - QIAGEN NVEarnings Call TranscriptsAll right, good afternoon, everyone. I'm Robbie Bamberger, Senior Research Analyst covering Life Sciences and Diagnostics here at Baird. We're pleased to welcome Kaijin this afternoon, especially pleased to Welcome John
1mo agoQGENMorgan Stanley 24th Annual Global Healthcare Conference - QIAGEN NVEarnings Call TranscriptsAmazing. Thank you, everyone, for joining us. Day two of Morgan Stanley's Global Healthcare Conference. I'm Callum Tishmarsh. I run the Life Science Tools and Diagnostics team. Really pleased today to be joined by Mark K
1mo agoQGENMorgan Stanley 24th Annual Global Healthcare Conference - QIAGEN NVEarnings Call TranscriptsAll right, welcome everyone to our Fireside Chat with QIAGEN. I'm Aisha Noor, Head of European MedTech Research at Morgan Stanley, and it's my pleasure to host QIAGen CEO Jonathan Pratt and CFO Roland Sackers today, as w
2mo agoQGENQIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid ExtractionBusiness WireNew IVD automation platform standardizes nucleic acid extraction across diverse assay workflows with improved productivity, sample traceability and process safety Builds on more than 3,300 cumulative placements of
2mo agoQGENQIAGEN Appoints Jonathan M. Pratt as Chief Executive OfficerBusiness WireJon Pratt brings more than 25 years of leadership experience, most recently as CEO of Filtration Group and previously at Waters, Beckman Coulter Life Sciences and Pall To assume CEO role on September 1, 2026,
3mo agoQGENQIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection PanelBusiness WireQIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour FDA clearance marks QIAGEN's entry into U.S. bloodstream
3mo agoQGENQIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year OutlookBusiness WireQ2 2026 results: Net sales of $535 million unchanged compared with Q2 2025 on a reported basis and at constant exchange rates (CER), exceeding the outlook for an about 2% CER decline Growth pillars deliver about
3mo agoQGENQIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora OutbreakBusiness WireMore than 1,600 U.S. cases of cyclosporiasis have been confirmed since May 2026 as infections linked to the foodborne parasite Cyclospora continue to rise nationwide QIAGEN’s FDA-cleared QIAstat-Dx
3mo agoQGENQIAGEN N.V. to Release Results for Q2 2026 and Hold WebcastBusiness WireQIAGEN N.V. (NYSE:QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the second quarter of 2026. Press release date / time: Wednesday, August 5 shortly after 22:05 Frankfurt time /
4mo agoQGENQIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in EuropeBusiness WireNew CE-IVDR-certified QIAstat-Dx BCID GN Plus AMR Panel detects 13 gram-negative bacterial pathogen targets and 18 antimicrobial resistance markers from positive blood cultures Together with the BCID GPF Plus AMR
5mo agoQGENQIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and BiopharmaBusiness WirePlanned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas Expanded Cell and Gene Therapy offerings and
5mo agoQGENQIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus OutbreakBusiness WireTwo custom-designed research-use-only (RUO) QIAcuity digital PCR assays now available to target Bundibugyo ebolavirus sequences associated with the current outbreak Assays designed for integration into existing
5mo agoQGENQIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflowsBusiness WireNew AI-powered scientific platform available on www.qiagen.com connects experiment planning, product discovery and workflow support through a single conversational interface Natural-language experience helps reduce
5mo agoQGENQIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIABusiness WireCollaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights' curated biomedical knowledge bases Goal to advance how disease mechanisms, therapeutic targets and
6mo agoQGENQIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General MeetingBusiness WireCo-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board after deciding not to stand for re-election Robert McMahon nominated for election to Supervisory Board as part of
6mo agoQGENQIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB TestingBusiness WireAmbition to support high-throughput laboratories in efficiently scaling latent tuberculosis (TB) screening as testing volumes continue to grow Fully automated workflow targeted for late 2027 launch integrates
6mo agoQGENQIAGEN Reports Full Results for Q1 2026Business WireQ1 2026 results in line with pre-announcement: Net sales rise 2% to $492 million on a reported basis, and -1% at constant exchange rates (CER) vs. outlook for at least 1% CER growth Sample technologies, QIAcuity
6mo agoQGENQIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlookBusiness WireSample technologies, QIAcuity and QDI deliver solid growth; QuantiFERON sales affected by significantly lower immigration testing demand QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced
6mo agoQGENQIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026Business WireHighlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, genomic profiling and data analysis QIAsymphony Connect will serve as a foundation for lab
7mo agoQGENQIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx PanelBusiness WireQIAstat-Dx BCID GPF Plus AMR Panel detects gram-positive bacteria, fungi and key antimicrobial resistance markers from positive blood cultures and colonies CE-IVDR-certified panel identifies 20 pathogens and 10
7mo agoQGENQiagen Announces Form 20-F Annual Report Filing for 2025 ResultsBusiness WireQIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2025,
7mo agoQGENQIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB PreventionBusiness WireNew study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various settings Findings show QuantiFERON testing is cost-effective compared with tuberculin skin testing in
8mo agoQGENQIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing SystemBusiness WireFDA clears Gastrointestinal (GI) Panels for use on the fully automated QIAstat-Dx Rise platform, marking the ninth U.S. QIAstat-Dx panel clearance in last 24 months Laboratories can now run respiratory and
8mo agoQGENParse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell RecoveryBusiness WireNew chemistry reduces barriers to scaling single-cell studies across research settings Launch planned for March 2026, available across Evercode Whole Transcriptome product line Parse Biosciences, a QIAGEN company
8mo agoQGENVÍDEO PARA QUEM QUISER ENVIAR UM RESUMO CIENTÍFICO PARA A CONFERÊNCIA DA UNION - QIAGEN NVEarnings Call TranscriptsWelcome to this module on how to write effective scientific summaries for the International Union Conference on Tuberculosis and Pulmonary Diseases, also known as the Union. This module was prepared by the scientific com
9mo agoQGENVÍDEO PARA QUEM QUISER ENVIAR UM RESUMO CIENTÍFICO PARA A CONFERÊNCIA DA UNION - QIAGEN NVEarnings Call TranscriptsWelcome to this module on how to write effective scientific summaries for the International Union's Annual Conference on Tuberculosis and Respiratory Diseases, also known as the Union. This module was prepared by the Sci
9mo agoQGENQIAGEN Exceeds Q4 2025 Outlook Driven by Growth PillarsBusiness WireQ4 2025: Net sales of $540 million (+4% at actual rates, +1% at constant exchange rates (CER)); diluted EPS of $0.49 and adjusted diluted EPS of $0.62 Net sales growth of 1% CER ahead of outlook for steady results
9mo agoQGENQIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026Business WireQIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible protocols, compact design and sustainability-focused features QIAGEN also to showcase new
9mo agoQGENA TUTORIAL FOR THOSE LOOKING TO SUBMIT AN ABSTRACT FOR THE UNION WORLD CONFERENCE ON LUNG HEALTH - QIAGEN NVEarnings Call TranscriptsWelcome to this module on writing effective scientific abstracts for the Union World Conference on Lung Health. This module has been prepared by the Conference Scientific Committee with input from the Union Training and
10mo agoQGENQIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 MillionBusiness WireReturn of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026 Capital return to be conducted through synthetic share repurchase – combines a fast direct capital
1y agoQGENQIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025Business WireQIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026 QIAGEN showcases Sample to Insight
1y agoQGENQIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share RepurchaseBusiness WireQ3 2025 results: Net sales of $533 million (+6% at actual rates); diluted EPS $0.60 Core sales +6% CER (constant exchange rates) driven by QIAstat-Dx (+11% CER), QuantiFERON (+11% CER) and Sample technologies (+3%
1y agoQGENQIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutionsBusiness WireParse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN's presence in the rapidly
1y agoQGENQIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025Business WireNew EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA Workflow on EZ2 Connect Fx delivers high-quality DNA in under 2.5
1y agoQGENQIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample ProcessingBusiness WireQIAcube Connect drives lab efficiency by automating critical steps in molecular biology workflows for both research and clinical customers Milestone builds on nearly 13,000 cumulative placements of QIAcube family
1y agoQGENQIAGEN N.V. to Release Results for Q3 2025 and Hold WebcastBusiness WireQIAGEN N.V. (NYSE:QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the third quarter of 2025. Press release date / time: Tuesday, November 4, shortly after 22:05 Frankfurt time /
1y agoQGENQIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx PortfolioBusiness WireFull portfolio of QIAstat-Dx panels now CE-IVDR certified for use in clinical syndromic testing, underscoring commitment to highest-quality diagnostics CE-IVDR clearance granted for QIAstat-Dx
1y agoQGENQiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Prepared Remarks TranscriptEarnings Call Transcripts
1y agoQGENQiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 TranscriptEarnings Call Transcripts
1y agoQGENQiagen N.V. (QGEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
1y agoQGENQIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic TestingBusiness WireU.S. market entry set to begin for QIAstat-Dx Rise – a version of QIAstat-Dx for syndromic testing that combines unparalleled throughput with the easiest workflow QIAstat-Dx Rise launch can process up to 160 samples